Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Clinical Neuropharmacology|October 24, 2017
Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson DiseaseJoseph Bergman, Paul P Lerner, Shmuel Sokolik, et al.
The Journal of Clinical Psychiatry|January 13, 2006
High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesiaVladimir Lerner, Chanoch Miodownik, Alexander Kaptsan, et al.
Clinical Neuropharmacology|August 2, 2008
Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesiaChanoch Miodownik, Aviel Meoded, Igor Libov, et al.
Clinical Neuropharmacology|April 15, 2006
Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled studyChanoch Miodownik, Vladimir Lerner, Nikolay Statsenko, et al.
Psychological Reports|November 6, 2008
Psychologists' and social workers' self-descriptions using DSM-IV psychopathologyTali Nachshoni, Yehuda Abramovitch, Vladimir Lerner, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 23, 2010
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivationAnatoly Kreinin, Chanoch Miodownik, Shmuel Sokolik, et al.
Frontiers in Psychiatry|May 14, 2023
Case report: Anorexia nervosa and unspecified restricting-type eating disorder in Jewish ultra-orthodox religious males, leading to severe physical and psychological morbiditySofia Laufer, Estee Herman, David Serfaty, et al.
The Journal of Clinical Psychiatry|January 7, 2011
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center studyMichael S Ritsner, Chanoch Miodownik, Yael Ratner, et al.
Clinical Neuropharmacology|February 28, 2008
Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trialVladimir Lerner, Chanoch Miodownik, Anatoly Gibel, et al.
Clinical Neuropharmacology|May 16, 2013
Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical studyJoseph Bergman, Chanoch Miodownik, Yuly Bersudsky, et al.
Pageof 10